Annual Accounts Payable
$313.49 M
+$95.99 M+44.14%
March 31, 2024
Summary
- As of February 6, 2025, RDY annual accounts payable is $313.49 million, with the most recent change of +$95.99 million (+44.14%) on March 31, 2024.
- During the last 3 years, RDY annual accounts payable has risen by +$140.64 million (+81.36%).
- RDY annual accounts payable is now at all-time high.
Performance
RDY Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$419.91 M
-$7.44 M-1.74%
December 31, 2024
Summary
- As of February 6, 2025, RDY quarterly accounts payable is $419.91 million, with the most recent change of -$7.44 million (-1.74%) on December 31, 2024.
- Over the past year, RDY quarterly accounts payable has increased by +$11.18 million (+2.74%).
- RDY quarterly accounts payable is now -1.74% below its all-time high of $427.34 million, reached on September 30, 2024.
Performance
RDY Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RDY Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.1% | +2.7% |
| 3 y3 years | +81.4% | +2.7% |
| 5 y5 years | +111.5% | +68.7% |
RDY Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +81.4% | -1.7% | +99.4% |
| 5 y | 5-year | at high | +120.0% | -1.7% | +194.7% |
| alltime | all time | at high | +2025.3% | -1.7% | +1980.8% |
Dr Reddys Laboratories Limited Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $419.91 M(-1.7%) |
| Sep 2024 | - | $427.34 M(+4.6%) |
| Jun 2024 | - | $408.73 M(+58.2%) |
| Mar 2024 | $313.49 M(+44.1%) | $258.37 M(-30.7%) |
| Dec 2023 | - | $372.70 M(+1.7%) |
| Sep 2023 | - | $366.37 M(+8.6%) |
| Jun 2023 | - | $337.28 M(+55.1%) |
| Mar 2023 | $217.50 M(+3.3%) | $217.50 M(-30.8%) |
| Dec 2022 | - | $314.44 M(+12.5%) |
| Sep 2022 | - | $279.55 M(-12.0%) |
| Jun 2022 | - | $317.51 M(+50.7%) |
| Mar 2022 | $210.63 M(+21.9%) | $210.63 M(-36.0%) |
| Dec 2021 | - | $329.05 M(-4.3%) |
| Sep 2021 | - | $343.80 M(-10.7%) |
| Jun 2021 | - | $385.08 M(+122.8%) |
| Mar 2021 | $172.86 M(+21.3%) | $172.86 M(-45.0%) |
| Dec 2020 | - | $314.13 M(+1.9%) |
| Sep 2020 | - | $308.18 M(+22.6%) |
| Jun 2020 | - | $251.34 M(+76.4%) |
| Mar 2020 | $142.47 M(-3.9%) | $142.47 M(-42.8%) |
| Dec 2019 | - | $248.89 M(+13.7%) |
| Sep 2019 | - | $218.87 M(+2.3%) |
| Jun 2019 | - | $214.04 M(+44.4%) |
| Mar 2019 | $148.25 M(+4.8%) | $148.25 M(-34.9%) |
| Dec 2018 | - | $227.88 M(+17.4%) |
| Sep 2018 | - | $194.05 M(-9.9%) |
| Jun 2018 | - | $215.28 M(+52.2%) |
| Mar 2018 | $141.43 M | $141.43 M(-38.0%) |
| Dec 2017 | - | $228.24 M(+5.1%) |
| Sep 2017 | - | $217.15 M(+6.4%) |
| Jun 2017 | - | $204.06 M(+4.2%) |
| Dec 2016 | - | $195.89 M(+6.6%) |
| Sep 2016 | - | $183.72 M(-2.6%) |
| Jun 2016 | - | $188.68 M(+6.0%) |
| Dec 2015 | - | $177.97 M(-8.1%) |
| Sep 2015 | - | $193.66 M(+7.8%) |
| Jun 2015 | - | $179.62 M(-7.6%) |
| Dec 2014 | - | $194.49 M(-6.8%) |
| Sep 2014 | - | $208.57 M(+17.7%) |
| Jun 2014 | - | $177.16 M(+12.4%) |
| Dec 2013 | - | $157.66 M(-8.4%) |
| Sep 2013 | - | $172.06 M(+2.8%) |
| Jun 2013 | - | $167.36 M(-16.6%) |
| Dec 2012 | - | $200.79 M(+2.2%) |
| Sep 2012 | - | $196.37 M(+27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $154.00 M(-11.1%) |
| Dec 2011 | - | $173.21 M(-5.3%) |
| Sep 2011 | - | $182.82 M(-2.8%) |
| Jun 2011 | - | $188.14 M(-1.0%) |
| Mar 2011 | $189.95 M(-8.6%) | $189.95 M(+15.2%) |
| Dec 2010 | - | $164.91 M(-25.5%) |
| Sep 2010 | - | $221.42 M(+6.2%) |
| Jun 2010 | - | $208.51 M(+0.3%) |
| Mar 2010 | $207.79 M(+75.9%) | $207.79 M(+63.1%) |
| Dec 2009 | - | $127.39 M(-15.3%) |
| Sep 2009 | - | $150.44 M(+4.5%) |
| Jun 2009 | - | $143.92 M(+21.8%) |
| Mar 2009 | $118.12 M(-12.7%) | $118.12 M(-15.4%) |
| Dec 2008 | - | $139.63 M(-20.8%) |
| Sep 2008 | - | $176.26 M(-2.3%) |
| Jun 2008 | - | $180.40 M(+33.3%) |
| Mar 2008 | $135.30 M(+22.2%) | $135.30 M(+0.0%) |
| Dec 2007 | - | $135.28 M(-9.9%) |
| Sep 2007 | - | $150.21 M(+14.5%) |
| Jun 2007 | - | $131.21 M(+18.5%) |
| Mar 2007 | $110.73 M(+35.1%) | $110.73 M(-13.9%) |
| Dec 2006 | - | $128.60 M(-38.7%) |
| Sep 2006 | - | $209.65 M(+24.2%) |
| Jun 2006 | - | $168.86 M(+106.1%) |
| Mar 2006 | $81.94 M(+152.4%) | $81.94 M(+71.5%) |
| Dec 2005 | - | $47.78 M(+11.9%) |
| Sep 2005 | - | $42.72 M(+1.0%) |
| Jun 2005 | - | $42.30 M(+30.3%) |
| Mar 2005 | $32.46 M(-35.4%) | $32.46 M(-12.0%) |
| Dec 2004 | - | $36.89 M(-25.2%) |
| Sep 2004 | - | $49.31 M(+0.2%) |
| Jun 2004 | - | $49.22 M(-2.1%) |
| Mar 2004 | $50.28 M(+44.7%) | $50.28 M(+8.8%) |
| Dec 2003 | - | $46.24 M(-2.5%) |
| Sep 2003 | - | $47.40 M(+8.0%) |
| Jun 2003 | - | $43.91 M(+26.4%) |
| Mar 2003 | $34.75 M(+51.0%) | $34.75 M(+2.8%) |
| Dec 2002 | - | $33.81 M(+8.1%) |
| Sep 2002 | - | $31.27 M(-1.9%) |
| Jun 2002 | - | $31.89 M(+38.6%) |
| Mar 2002 | $23.01 M(+56.0%) | $23.01 M(+5.5%) |
| Dec 2001 | - | $21.82 M(+8.1%) |
| Sep 2001 | - | $20.18 M(-30.2%) |
| Jun 2001 | - | $28.91 M |
| Mar 2001 | $14.75 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual accounts payable?
- What is the all time high annual accounts payable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual accounts payable year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly accounts payable year-on-year change?
What is Dr Reddys Laboratories Limited annual accounts payable?
The current annual accounts payable of RDY is $313.49 M
What is the all time high annual accounts payable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual accounts payable is $313.49 M
What is Dr Reddys Laboratories Limited annual accounts payable year-on-year change?
Over the past year, RDY annual accounts payable has changed by +$95.99 M (+44.14%)
What is Dr Reddys Laboratories Limited quarterly accounts payable?
The current quarterly accounts payable of RDY is $419.91 M
What is the all time high quarterly accounts payable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly accounts payable is $427.34 M
What is Dr Reddys Laboratories Limited quarterly accounts payable year-on-year change?
Over the past year, RDY quarterly accounts payable has changed by +$11.18 M (+2.74%)